MedTrace Logo

Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma

NCT02769806 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2023-01-17

No results posted yet for this study

Summary

The primary aim of this project is to Compare new msCS and standard DSC-PWI methods in GBM patients undergoing post-operative MRI for monitoring of tumor progression.

Conditions

Interventions

PROCEDURE

MRI

Sponsors & Collaborators

  • National Institute for Biomedical Imaging and Bioengineering (NIBIB)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Alexey Samsonov · University of Wisconsin, Madison

Eligibility

Min Age
18 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-23
Primary Completion
2019-06-21
Completion
2019-06-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02769806 on ClinicalTrials.gov